Implantation of Cultured Preadipocyte Using Chitosan/Alginate Sponge

2007 ◽  
Vol 342-343 ◽  
pp. 349-352 ◽  
Author(s):  
Jong Won Rhie ◽  
Jin Kyung Song ◽  
Paik Kwon Lee ◽  
Sang Tae Ahn

Alginate was a proven biocompatible biomatrice for cells but it was known not to provide a proper microenvironment needed for the proliferation of cells because of its anionic property, which caused its low affinity for cells. Water-soluble chitosan was well known as wound healing material and it also had cationic property which helped cell-to-matrix adhesion. The purpose of this study is to assess the ability of a chitosan/alginate mixed sponge as a scaffold for preadipocytes to serve as a biological implant for soft tissue augmentation. Chitosan/alginate and calcium alginate sponges were made by lyophilizing of alginate with water-soluble chitosan mixture and with calcium chloride mixture, respectively, and those were observed by SEM. Preadipocytes seeded in those sponges were cultured for 2 weeks. In vivo study was designed that chitosan/alginate sponges with and without preadipocytes were implanted subcutaneously into nude mouse. Chitosan/alginate and calcium alginate sponges which had highly porosity and 50-200㎛ pore size. In the chitosan/alginate sponge, the levels of DNA amount were significantly higher than those in calcium alginate sponge (P<0.05). In both groups, they increased progressively with time. On the in vivo study, it was observed that adipose tissue layer in the margin of chitosan/alginate sponge on the 2 weeks after implantation of nude mouse. On the 8 weeks after implantation, thick layer of adipose tissue and neovascularization were observed in the chitosan/alginate sponge. Consequently, chitosan/alginate sponge provided proper microenvironment to human preadipocyte, increased the cell proliferation and maintained the pore that offered neovascularization, so turned out to be effective form of fat transplantation for soft tissue augmentation and reconstruction.

2009 ◽  
Vol 80 (11) ◽  
pp. 1852-1858 ◽  
Author(s):  
Olivier Etienne ◽  
Aurore Schneider ◽  
Jonathan A. Kluge ◽  
Claire Bellemin-Laponnaz ◽  
Camille Polidori ◽  
...  

2017 ◽  
Vol 105 (6) ◽  
pp. 1756-1764 ◽  
Author(s):  
Qiu-Wen Tan ◽  
Yi Zhang ◽  
Jing-Cong Luo ◽  
Di Zhang ◽  
Bin-Jun Xiong ◽  
...  

2008 ◽  
Vol 69 (1) ◽  
pp. 148-156 ◽  
Author(s):  
James L. Cook ◽  
Derek B. Fox ◽  
Keiichi Kuroki ◽  
Manuel Jayo ◽  
Patrick G. De Deyne

2016 ◽  
Vol 11 (4) ◽  
pp. 377-386
Author(s):  
Li-Ting Li ◽  
Kuang-Ta Yao ◽  
Shou-Cheng Teng ◽  
Tiffany P. Sun ◽  
Ching-Kuo Chen ◽  
...  

2005 ◽  
Vol 22 (2) ◽  
pp. 105-108 ◽  
Author(s):  
James Chan ◽  
Aniq B. Darr ◽  
Daniel Alam ◽  
Anthony Calabro

Objective: To investigate an innovative tyramine-based hyaluronan (TB-HA) biomaterial for soft-tissue augmentation. Specifically, to test: (1) the ability of the TB-HA biomaterial to be injected subcutaneously; and (2) to test the in vivo response of the TB-HA biomaterial in an immunocompetent animal model. Introduction: Hyaluronan (HA) is a normal component of most tissues and, as such, is nonimmunogenic, nontoxic, and noninflammatory. Cross-linked hydrogels are formed from HA by substitution (approximately 5%) with tyramine followed by enzymatic cross-linking with peroxidase in the presence of very dilute hydrogen peroxide. From a single formulation of tyramine-substituted HA (TS-HA), a full spectrum of biomaterial properties can be produced by varying the HA concentration before cross-linking. The properties of these biomaterials ranged from a soft, optically clear hydrogel (6.25 mg/mL), suitable for soft-tissue augmentation as an injectable material, to a paste-like material (12.5–25.0 mg/mL). Materials and Methods: The hydrogel was evaluated in vivo as an injectable material (6.25 mg/mL). The material was injected into the subcutaneous tissue of an adult Sprague-Dawley rat, harvested at 8 weeks, and evaluated grossly and histologically. The specimens were paraffin embedded, sectioned on a microtome, and stained with hematoxylin and eosin. Results: In vivo analysis of the TB-HA hydrogels at 8 weeks revealed that they were resistant to degradation. Histological analysis revealed no evidence of rejection or tissue inflammatory response. Conclusions: Novel enzymatic cross-linking of HA enables the development of a versatile new biomaterial that can be used for soft-tissue augmentation. Preliminary in vivo analysis in an immunocompetent rat model revealed that the hydrogel material resisted degradation and did not elicit a host inflammatory response.


Polymers ◽  
2020 ◽  
Vol 12 (8) ◽  
pp. 1845
Author(s):  
Manuel Toledano ◽  
Manuel Toledano-Osorio ◽  
Álvaro Carrasco-Carmona ◽  
Cristina Vallecillo ◽  
Raquel Toledano ◽  
...  

Most of the polymers used as biomaterials for scaffolds are naturally occurring, synthetic biodegradable, and synthetic non-biodegradable polymers. Since synthetic polymers can be adapted for obtaining singular desired characteristics by applying various fabrication techniques, their use has increased in the biomedical field, in dentistry in particular. The manufacturing methods of these new structures include many processes, such as electrospinning, 3D printing, or the use of computer-aided design/computer-aided manufacturing (CAD/CAM). Synthetic polymers show several drawbacks that can limit their use in clinical applications, such as the lack of cellular recognition, biodegradability, and biocompatibility. Moreover, concerning biodegradable polymers, the time for matrix resorption is not predictable, and non-resorbable matrices are preferred for soft tissue augmentation in the oral cavity. This review aimed to determine a new biomaterial to offset the present shortcomings in the oral environment. Researchers have recently proposed a novel non-resorbable composite membrane manufactured via electrospinning that has allowed obtaining remarkable in vivo outcomes concerning angiogenesis and immunomodulation throughout the polarization of macrophages. A prototype of the protocol for in vitro and in vivo experimentation with hydrogels is explained in order to encourage innovation into the development of promising biomaterials for soft tissue augmentation in the near future.


2018 ◽  
Vol 6 (10) ◽  
pp. 2627-2638 ◽  
Author(s):  
Won Il Choi ◽  
Youngmin Hwang ◽  
Abhishek Sahu ◽  
Kiyoon Min ◽  
Daekyung Sung ◽  
...  

A novel levan-based injectable hydrogel was developed as a dermal filler having better in vivo stability and efficacy compared to HA-based hydrogel.


Sign in / Sign up

Export Citation Format

Share Document